MedTrace Logo

EEG Biofeedback to Improve Memory in Adults With Dementia

NCT01168466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2018-04-02

No results posted yet for this study

Summary

This study measures whether the symptoms of frontotemporal dementia (FTD) can be successfully treated by (a) biofeedback training to increase brain blood flow, (b) biofeedback to increase the frequency of the brain's dominant brainwave rhythm, and (c) rhythmic stimulation to increase the brain's dominant brainwave frequency.

Conditions

Interventions

BEHAVIORAL

QEEG-based Neurofeedback Training

EEG amplitude is measured and visual and auditory rewards are given when amplitude at specific locations is modified to meet preset threshholds.

Sponsors & Collaborators

  • Quietmind Foundation

    lead OTHER

Principal Investigators

  • Marvin H Berman, Ph.D. · Quietmind Foundation

  • Jon Frederick, Ph.D. · Quietmind Foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01168466 on ClinicalTrials.gov